HuGE Literature Finder
|
||
Records 1-3
|
Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer.
Oncogene 2015 Apr 34 (16): 2125-37. Chen X, Paranjape T, Stahlhut C, McVeigh T, Keane F, Nallur S, Miller N, Kerin M, Deng Y, Yao X, Zhao H, Weidhaas J B, Slack F |
|
Assessment of hepatocyte growth factor in ovarian cancer mortality.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011 Aug 20 (8): 1638-48. Goode Ellen L, Chenevix-Trench Georgia, Hartmann Lynn C, Fridley Brooke L, Kalli Kimberly R, Vierkant Robert A, Larson Melissa C, White Kristin L, Keeney Gary L, Oberg Trynda N, Cunningham Julie M, Beesley Jonathan, Johnatty Sharon E, Chen Xiaoqing, Goodman Katelyn E, Armasu Sebastian M, Rider David N, Sicotte Hugues, Schmidt Michele M, Elliott Elaine A, Høgdall Estrid, Kjær Susanne Krüger, Fasching Peter A, Ekici Arif B, Lambrechts Diether, Despierre Evelyn, Høgdall Claus, Lundvall Lene, Karlan Beth Y, Gross Jenny, Brown Robert, Chien Jeremy, Duggan David J, Tsai Ya-Yu, Phelan Catherine M, Kelemen Linda E, Peethambaram Prema P, Schildkraut Joellen M, Shridhar Vijayalakshmi, Sutphen Rebecca, Couch Fergus J, Sellers Thomas A, |
|
The predictive value of serum VEGF in multiresistant ovarian cancer patients treated with bevacizumab.
Gynecologic oncology 2010 Aug 118 (2): 167-71. Smerdel M P, Steffensen K D, Waldstrøm M, Brandslund I, Jakobsen |
- Page last reviewed:Jul 30, 2019
- Page last updated:Oct 10, 2019
- Content source: